Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

PureTech (PRTC)

Price 166.40p on 19-07-2024 at 16:30:01
Change -2.80p -1.65%
Buy 166.20p
Sell 165.60p
Buy / Sell PRTC Shares
Last Trade: Sell 162,837.00 at 166.40p
Day's Volume: 429,033
Last Close: 166.40p
Open: 171.00p
ISIN: GB00BY2Z0H74
Day's Range 165.40p - 171.00p
52wk Range: 139.00p - 238.50p
Market Capitalisation: £398m
VWAP: 166.93215p
Shares in Issue: 239m

Recent Trades History PureTech (PRTC)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 162,837 166.40p Uncrossing Trade
15:35:06 - 19-Jul-24
Buy* 465 166.00p Automatic Execution
15:29:52 - 19-Jul-24
Sell* 44 165.80p Automatic Execution
15:29:47 - 19-Jul-24
Sell* 39 166.00p Automatic Execution
15:29:47 - 19-Jul-24
Sell* 143 166.20p Automatic Execution
15:29:25 - 19-Jul-24
Sell* 7 166.40p Automatic Execution
15:28:38 - 19-Jul-24
Sell* 156 166.40p Automatic Execution
15:28:15 - 19-Jul-24
Buy* 119 166.80p Automatic Execution
15:28:15 - 19-Jul-24
Buy* 146 166.80p Automatic Execution
15:28:15 - 19-Jul-24
Buy* 56 166.80p Automatic Execution
15:28:15 - 19-Jul-24

Share Price History for PureTech

Time period:
to
Date Open High Low Close Volume

Share News for PureTech

EARNINGS AND TRADING: PureTech seals tender offer; HL bid questioned

24th Jun 2024 19:46

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

IN BRIEF: PureTech's Ankili to be acquired by Virtual Therapeutics

29th May 2024 21:30

PureTech Health PLC - London-listed Biotech company headquartered in Boston - Says Tuesday that founded entity, Ankili Inc, a game developer focusing on improving mental health, will merge with Virtual Therapeutics Corp, a Boston-based digital therapeutics company. As of May 7, PureTech owned over 12.5 million of Ankili common stock. Read More

PureTech-founded Vedanta begins trials for VE303 colonic bacteria drug

21st May 2024 14:07

(Alliance News) - PureTech Health PLC on Tuesday said that a company it founded and in which it maintains a stake had begun trials of a new treatment for clostridioides difficile infection, in the hopes of moving toward regulatory approval. Read More

IN BRIEF: PureTech Health launches USD100 million buyback programme

20th May 2024 09:03

PureTech Health PLC - London-based biotherapeutics company - Launches tender offer to repurchase shares for a maximum consideration of USD100 million. The offer, set to run until June 18, will be for up to 33.5 million shares, around 12% of PureTech's share capital, at a fixed price of 250 pence each. Read More

EARNINGS AND TRADING: Asiamet Resources declares special dividend

10th May 2024 16:39

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

FTSE 100 Latest
Value8,155.72
Change-49.17

Login to your account

Forgot Password?

Not Registered